FDA bars from industry man convicted of selling foreign-made drugs

Talib Khan is already doing time in federal facility in Philadelphia, but the FDA has let him know that once he is out, he is barred from ever working for any company that sells FDA-approved drugs. Khan was one of the owners of the Arlington, VA-based Gallant Pharma International. The feds closed the company in 2013 for selling foreign versions of Botox and cancer drugs on the black market, often receiving the drugs in a condition that left their quality and sterility in question. Khan and his partner, Syed "Farhan" Huda, and employees of the company pleaded guilty to federal charges in 2013. Here's a notice of the ban (PDF) | More

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.